Zovighian Bernard J 4
4 · Edwards Lifesciences Corp · Filed Jun 3, 2025
Insider Transaction Report
Form 4
Zovighian Bernard J
DirectorCEO
Transactions
- Sale
Common Stock
2025-06-03$77.32/sh−967$74,772→ 8,596.551 total(indirect: By Trust) - Sale
Common Stock
2025-05-30$77.21/sh−16,099$1,243,065→ 9,563.551 total(indirect: By Trust)
Holdings
- 3,605.849(indirect: By 401(k))
Common Stock
- 80,976
Common Stock
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $76.930 to $77.585 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $77.140 to $77.540 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.